Impact of disease modifying therapy on fatigue among multiple sclerosis patients

被引:0
|
作者
Elkhooly, Mahmoud [1 ,2 ]
Raghib, Muhammad [1 ]
Lazar, Emily [1 ]
Lazar, Adam [1 ]
Liaquat, Zaima [1 ]
Martinez, Carla [1 ]
Rube, Jacob [1 ]
Bernitsas, Evanthia [1 ]
机构
[1] Wayne State Univ, Neurol, Detroit, MI USA
[2] Minia Univ, Neurol & Psychiat, Al Minya, Egypt
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P1620/2035
引用
收藏
页码:1028 / 1028
页数:1
相关论文
共 50 条
  • [31] Disease-Modifying Therapy of Pediatric Multiple Sclerosis
    Tanuja Chitnis
    Neurotherapeutics, 2013, 10 : 89 - 96
  • [32] Monoclonal Antibodies as Disease Modifying Therapy in Multiple Sclerosis
    Longbrake, Erin E.
    Parks, Becky J.
    Cross, Anne H.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2013, 13 (11)
  • [33] Disease modifying therapy in the aging multiple sclerosis patient
    Corboy, J. R.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 83 - 83
  • [34] Multiple sclerosis disease-modifying therapy and pregnancy
    Miller, Aaron E.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : 715 - 716
  • [35] Disease-Modifying Therapy of Pediatric Multiple Sclerosis
    Chitnis, Tanuja
    NEUROTHERAPEUTICS, 2013, 10 (01) : 89 - 96
  • [36] Balancing the benefits and risks of disease-modifying therapy in patients with multiple sclerosis
    Sorensen, Per Soelberg
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2011, 311 : S29 - S34
  • [37] Factors Affecting the Adherence to Disease-Modifying Therapy in Patients With Multiple Sclerosis
    von Gaudecker, Jane R.
    JOURNAL OF NEUROSCIENCE NURSING, 2018, 50 (05) : 302 - 302
  • [38] Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis
    F. Schweitzer
    S. Laurent
    G. R. Fink
    Michael H. Barnett
    H. P. Hartung
    C. Warnke
    Journal of Neurology, 2021, 268 : 2379 - 2389
  • [39] Disease Modifying Therapy Discontinuation in Patients with Multiple Sclerosis Over Age 60
    Hua, Le H.
    Fan, Huijun
    Conway, Devon
    Kinzy, Tyler G.
    Thompson, Nicolas
    NEUROLOGY, 2017, 88
  • [40] An Update on the Use of Disease-Modifying Therapy in Pregnant Patients with Multiple Sclerosis
    Caila Vaughn
    Aisha Bushra
    Channa Kolb
    Bianca Weinstock-Guttman
    CNS Drugs, 2018, 32 : 161 - 178